Treatment with thermal ablation was noninferior to surgical resection in small-size colorectal liver metastases, according to ...
Marwan G. Fakih, MD, discusses the next steps for the clinical development of the balstilimab plus botensilimab in ...
A new technology from researchers at the California NanoSystems Institute at UCLA is aiming to turn the tables on tumors that ...
Some patients are better candidates than others for histotripsy to treat liver tumors, but ultimately, this treatment still ...
News-Medical.Net on MSN5d
Targeted nanoparticles show promise in preventing pancreatic cancer spread to the liverPancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...
Plectin drives hepatocellular carcinoma progression and metastasis through cytoskeletal reorganization and oncogenic signaling, making it a promising therapeutic target for overcoming therapy ...
Two new drugs to treat prostate and liver cancer have been given the green light for use by the NHS in Scotland. The Scottish ...
Additional Phase 2 data for vilastobart,a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with MSS CRC ...
About Delcath Systems, Inc., HEPZATO KIT and CHEMOSAT Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company's ...
Identification of pathway provides mechanistic insights into the anti-metastatic effects of aspirin, as a potential basis for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback